Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.

[1]  Deepak L. Bhatt,et al.  Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions , 2003, Circulation.

[2]  R. Bonow,et al.  Troponin I elevation and cardiac events after percutaneous coronary intervention. , 2003, American heart journal.

[3]  R. Erbel,et al.  Preprocedural Statin Medication Reduces the Extent of Periprocedural Non–Q-Wave Myocardial Infarction , 2002, Circulation.

[4]  A. Sposito,et al.  Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[5]  E. Topol,et al.  Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy , 2002, Circulation.

[6]  R. Erbel,et al.  Prognostic implication of cardiac troponin T increase following stent implantation , 2002, Heart.

[7]  Deepak L. Bhatt,et al.  Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention , 2002, Circulation.

[8]  E. Topol,et al.  &bgr;-Blockers Before Percutaneous Coronary Intervention Do Not Attenuate Postprocedural Creatine Kinase Isoenzyme Rise , 2001, Circulation.

[9]  J. Tcheng,et al.  Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. , 2001, Journal of the American College of Cardiology.

[10]  G. Stone,et al.  Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention , 2001 .

[11]  G. Stone,et al.  Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients , 2001, Circulation.

[12]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[13]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[14]  A. Kini,et al.  Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. , 2000, Circulation.

[15]  P. Meraj,et al.  Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect , 2000, Thrombosis and Haemostasis.

[16]  G. Stone,et al.  Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. , 2000, Journal of the American College of Cardiology.

[17]  P. Libby,et al.  HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Samin K. Sharma,et al.  Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. , 1999, Journal of the American College of Cardiology.

[19]  S. Steinhubl,et al.  The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions. , 1998, Journal of the American College of Cardiology.

[20]  R. Rosenson,et al.  Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. , 1998, JAMA.

[21]  P. Libby,et al.  Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. , 1998, Journal of the American College of Cardiology.

[22]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[23]  V. Paul,et al.  Recruited collateral channels are not responsible for ischemic preconditioning during single vessel angioplasty , 1998 .

[24]  A. Michael,et al.  Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. , 2003, British journal of clinical pharmacology.

[25]  R. Bonow,et al.  Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.

[26]  E. Topol,et al.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. , 1996, Circulation.

[27]  Y. Tsujita,et al.  Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[28]  A. Simon,et al.  Platelet cytosolic Ca2+ and membrane dynamics in patients with primary hypercholesterolemia. Effects of pravastatin. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[29]  G. Davı̀,et al.  Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Johan H. C. Reiber,et al.  Progress in quantitative coronary arteriography , 2012, Developments in Cardiovascular Medicine.

[31]  D. Baim,et al.  Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. , 1994, The American journal of cardiology.

[32]  G. Davı̀,et al.  Inhibition of throm☐ane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia , 1994 .

[33]  R. Califf,et al.  A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease , 1993 .

[34]  L. Klein,et al.  Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[35]  V. Fuster,et al.  Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  R. Colman,et al.  Platelet function in hyperlipoproteinemia. , 1974, The New England journal of medicine.